Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.91M Sell
21,832
-122
-0.6% -$41.8K 0.46% 51
2026
Q1
$7.72M Buy
21,954
+54
+0.2% +$19.3K 0.49% 50
2025
Q4
$7.17M Sell
21,900
-454
-2% -$144K 0.51% 41
2025
Q3
$6.31M Sell
22,354
-575
-3% -$167K 0.46% 47
2025
Q2
$6.4M Sell
22,929
-80
-0.3% -$22.7K 0.5% 40
2025
Q1
$7.17M Sell
23,009
-391
-2% -$115K 0.58% 36
2024
Q4
$6.1M Sell
23,400
-48
-0.2% -$14.2K 0.48% 44
2024
Q3
$7.55M Buy
23,448
+95
+0.4% +$31.1K 0.53% 37
2024
Q2
$7.3M Buy
+23,353
New +$6.86M 0.56% 36
2023
Q4
$6.72M Sell
23,323
-3,562
-13% -$971K 0.58% 42
2023
Q3
$7.23M Sell
26,885
-1,475
-5% -$368K 0.65% 35
2023
Q2
$6.3M Hold
28,360
0.54% 39
2023
Q1
$6.86M Sell
28,360
-538
-2% -$132K 0.63% 37
2022
Q4
$7.59M Sell
28,898
-3,090
-10% -$828K 0.72% 34
2022
Q3
$7.21M Sell
31,988
-1,097
-3% -$266K 0.76% 34
2022
Q2
$8.05M Sell
33,085
-789
-2% -$193K 0.81% 34
2022
Q1
$8.19M Sell
33,874
-289
-0.8% -$66.4K 0.7% 39
2021
Q4
$7.69M Sell
34,163
-887
-3% -$187K 0.66% 39
2021
Q3
$7.45M Sell
35,050
-483
-1% -$111K 0.69% 40
2021
Q2
$8.66M Sell
35,533
-216
-0.6% -$53.1K 0.78% 32
2021
Q1
$8.89M Hold
35,749
0.86% 29
2020
Q4
$8.22M Buy
35,749
+308
+0.9% +$71K 0.88% 28
2020
Q3
$9.01M Buy
35,441
+285
+0.8% +$70.6K 1.07% 23
2020
Q2
$8.29M Sell
35,156
-744
-2% -$170K 1.06% 24
2020
Q1
$7.28M Buy
35,900
+1,625
+5% +$355K 1.04% 24
2019
Q4
$8.26M Sell
34,275
-1,753
-5% -$386K 0.86% 32
2019
Q3
$6.97M Sell
36,028
-125
-0.3% -$24K 0.75% 38
2019
Q2
$6.66M Sell
36,153
-145
-0.4% -$26K 0.7% 42
2019
Q1
$6.9M Buy
36,298
+513
+1% +$98K 0.76% 41
2018
Q4
$6.97M Buy
35,785
+340
+1% +$66.3K 0.82% 35
2018
Q3
$7.35M Sell
35,445
-306
-0.9% -$60.3K 0.73% 38
2018
Q2
$6.6M Sell
35,751
-1,425
-4% -$252K 0.7% 40
2018
Q1
$6.34M Buy
37,176
+3,652
+11% +$670K 0.66% 42
2017
Q4
$5.83M Buy
33,524
+290
+0.9% +$51.3K 0.59% 47
2017
Q3
$6.2M Buy
33,234
+91
+0.3% +$16.1K 0.67% 42
2017
Q2
$5.71M Buy
33,143
+1,549
+5% +$252K 0.64% 43
2017
Q1
$5.18M Buy
31,594
+19
+0.1% +$3.16K 0.58% 46
2016
Q4
$4.62M Buy
31,575
+884
+3% +$133K 0.54% 48
2016
Q3
$5.12M Buy
30,691
+2,805
+10% +$474K 0.62% 43
2016
Q2
$4.24M Buy
27,886
+6,525
+31% +$1.01M 0.51% 49
2016
Q1
$3.48M Sell
21,361
-300
-1% -$44.6K 0.43% 57
2015
Q4
$3.52M Sell
21,661
-335
-2% -$52.7K 0.46% 57
2015
Q3
$3.04M Buy
21,996
+888
+4% +$140K 0.41% 59
2015
Q2
$3.24M Buy
21,108
+536
+3% +$85.9K 0.39% 59
2015
Q1
$3.29M Buy
20,572
+675
+3% +$106K 0.39% 59
2014
Q4
$3.17M Buy
19,897
+50
+0.3% +$7.79K 0.38% 55
2014
Q3
$2.79M Sell
19,847
-1,595
-7% -$208K 0.34% 62
2014
Q2
$2.54M Buy
21,442
+1,160
+6% +$134K 0.31% 64
2014
Q1
$2.5M Buy
20,282
+6,063
+43% +$735K 0.32% 63
2013
Q4
$1.62M Hold
14,219
0.22% 76
2013
Q3
$1.59M Hold
14,219
0.22% 73
2013
Q2
$1.4M Buy
+14,219
New +$1.48M 0.2% 80

Other funds holding AMGN

Lee, Danner & Bass's AMGN Position: Q2 2026 in Review

Lee, Danner & Bass reduced its Amgen (AMGN) stake by 0.56% in Q2 2026, selling an estimated $41.8K and leaving 21,832 shares worth $7.91M. The position accounts for 0.46% of the portfolio, ranked #51.

Lee, Danner & Bass first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.01M in Q3 2020. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Lee, Danner & Bass held 21,832 shares of Amgen worth $7.91M as of Q2 2026.
  • Lee, Danner & Bass sold 122 Amgen shares in Q2 2026, an estimated $41.8K.
  • Amgen made up 0.46% of Lee, Danner & Bass's portfolio in Q2 2026, its #51 holding.
  • Lee, Danner & Bass first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Lee, Danner & Bass's Amgen position peaked at $9.01M in Q3 2020.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Lee, Danner & Bass's 13F filing for Q2 2026, filed 21 Jul 2026.